Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0056
0.00 (0.00%)
At close: Mar 20, 2026
Market Cap392.55K -40.4%
Revenue (ttm)2.00K -97.6%
Net Income1.96M
EPS0.40
Shares Out70.10M
PE Ratio0.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume587,490
Average Volume266,732
Open0.0054
Previous Close0.0056
Day's Range0.0050 - 0.0058
52-Week Range0.0050 - 0.1700
Beta0.17
RSI42.66
Earnings DateApr 3, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements